Exclusivity of Cellectis Program Targets Sample Clauses
The Exclusivity of Cellectis Program Targets clause establishes that certain research or development targets are reserved solely for Cellectis, preventing the other party from working on or pursuing these targets independently or with third parties. In practice, this means that any intellectual property, research, or commercial activities related to the specified targets are restricted to Cellectis, and the partner must refrain from engaging in similar work that could compete or overlap. This clause is essential for protecting Cellectis’s competitive advantage and investment in its proprietary targets, ensuring that its efforts are not undermined by parallel activities from collaborators or competitors.
Exclusivity of Cellectis Program Targets. During the Research Term, until the earlier of (i) completion or termination of the Research Term or (ii) the filing by Cellectis of an IND for a Cellectis Program Target (together the “Cellectis Program Target Non-Compete Period”), neither Pfizer nor any of its Affiliates will (a) grant, or seek to grant, any right under any Pfizer Technology, Pfizer Improvements, Cellectis Improvements licensed to Pfizer pursuant to Section 4.1.2 or Developed IP Controlled by Pfizer to any Third Party with respect to such Cellectis Program Target in the Field or (b) use any Pfizer Technology, Pfizer Improvements, Cellectis Improvements licensed to Pfizer pursuant to Section 4.1.2 or Developed IP Controlled by Pfizer to Develop (itself or through or with a Third Party) or Commercialize T-cells expressing a chimeric antigen receptor construct Targeting such Cellectis Program Target in the Field. For clarity, in the event that Cellectis files an IND for a product for a Cellectis Program Target or enters into an agreement with a Third Party related to such Cellectis Program Target, other than academic institutions solely for internal academic non-profit research, non-commercial research collaborations, or subcontractors for a Cellectis Program Target then the Cellectis Program Target Non-Compete Period will terminate at such time for such Cellectis Program Target, but will remain in effect for all other Cellectis Program Targets, pursuant to terms of this Section 2.2.3.